Premature ejaculation is ejaculation that occurs shortly after penetration and before the person wishes. Because this can create dissatisfaction in both partners, it can create tension and anxiety that can, in turn, worsen the condition. Causes may include anxiety, depression, and more. Treating premature ejaculation may not be necessary, but when it is, your doctor can recommend lifestyle changes, medications, and techniques that can help treat the problem. Follow the links below to find WebMD’s comprehensive coverage about how premature ejaculation is caused, how to treat it, and much more.

To read more about premature ejaculation click here

What causes retrograde ejaculation?

ANSWER

These things can cause retrograde ejaculation:

• Prostate or urethral surgery
• Medication that keeps the bladder neck open
• Diabetes (which can injure the nerves that normally close the bladder during ejaculation)

Pills, Spray for Premature Ejaculation in Development

What could be bigger than a little blue pill that turned a common problem for the bedroom-challenged man into a marketing marvel, creating a $2.5 billion-a-year pharmaceutical niche that once featured a president wannabe as its prime-time pitchman?

Chris Every hopes it’s a mint-flavored tablet for what may be an even more common problem than impotence. He’s the CEO for Enhance Biotech, a company developing what could become the first pill specifically developed to treat rapid ejaculation — the new name for premature ejaculation, one of the most common sexual disorders in men. you can find all these at men’s clinic Pretoria, men’s clinic Durban, men’s clinic cape town, men’s clinic Johannesburg, men’s clinic Rustenburg, men’s clinic east London

Because relatively few men seek professional treatment for premature ejaculation, it’s estimated that about one in five guys is affected. That may be more than those with erectile dysfunction (ED). Rapid ejaculation occurs in virtually every man at some point in his life.

Since Viagra entered the market six years ago as the first ED oral agent, its success spawned two newer FDA-approved impotence drugs whose combined sales are estimated by some analysts to triple by decade’s end — to more than $6 billion annually.

Everyone’s drug, currently known as LI 301, is still in development, and wouldn’t hit the market until 2007, assuming it receives FDA approval. A recently completed preliminary trial involving 30 couples produced promising results, Everyone says. These study results have not been published.